Top

Published in:

Open Access 01-09-2008 | Original Article

IL-1B −31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers

Authors: R. Sitarz, W. W. J. de Leng, M. Polak, F. H. M. Morsink, O. Bakker, W. P. Polkowski, R. Maciejewski, G. J. A. Offerhaus, A. N. Milne

Published in: Virchows Archiv | Issue 3/2008

Abstract

It has been reported that interleukin-1beta (IL-1B) genes play a crucial role in the genetic predisposition to gastric cancer although there is no information about their role in different subtypes of gastric cancer. We performed single nucleotide polymorphism analysis of IL-1B in 241 gastric cancers including early onset gastric cancers (EOGC), conventional gastric cancers, and gastric stump cancers (GSCs) as well as 100 control patients, using real-time polymerase chain reaction and sequence analysis. The C allele was present in 60% of EOGCs, 59% of conventional gastric cancers, and 90% of GSCs, compared to 62% in the control group. Interestingly, there was no difference between early onset and conventional gastric cancer with respect to the IL-1B −31T>C polymorphism distribution. A statistically significant difference in the presence of the C allele compared to the control group was found in patients with gastric stump cancer (p = 0.008) with the T allele conferring protection against gastric stump cancer. In summary, we have shown that the IL-1B −31C allele promoter polymorphism is significantly associated with gastric stump cancer compared to the control group. Although several molecular differences have been identified between conventional gastric cancer and early onset gastric cancer, the IL-1B −31 allele distribution is similar between these two groups.

Amieva MR, El-Omar EM (2008) Host–bacterial interactions in Helicobacter pylori infection. Gastroenterology 134:306–323PubMedCrossRef

Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, La Greca A, D’Ugo D, La Torre G, van Duijn CM, Ricciardi G (2007) Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case–control study in an Italian population. BMC Cancer 7:206PubMedCrossRef

Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham ET, Goodman KJ, Piazuelo MB, Sicinschi L, Zabaleta J, Schneider BG (2006) Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1674–1687PubMedCrossRef

Carvalho R, Milne AN, Polak M, Corver WE, Offerhaus GJ, Weterman MA (2005) Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas. Oncogene 24:8252–8258PubMedCrossRef

Carvalho R, Milne AN, Polak M, Offerhaus GJ, Weterman MA (2006) A novel region of amplification at 11p12-13 in gastric cancer, revealed by representational difference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas. Genes Chromosomes Cancer 45:967–975PubMedCrossRef

Carvalho R, Milne AN, van Rees BP, Caspers E, Cirnes L, Figueiredo C, Offerhaus GJ, Weterman MA (2004) Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol 204:75–83PubMedCrossRef

Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15:519–529PubMedCrossRef

El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402PubMedCrossRef

El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS (2001) The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412:99PubMedCrossRef

10.

El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE (1997) Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113:15–24PubMedCrossRef

11.

Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302:1302–1305PubMedCrossRef

12.

Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-Menchaca R, Maldonado-Garza HJ, Perez-Perez GI (2005) Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 114:237–241PubMedCrossRef

13.

Gatti LL, Burbano RR, de Assumpcao PP, Smith Mde A, Payao SL (2004) Interleukin-1beta polymorphisms, Helicobacter pylori infection in individuals from northern Brazil with gastric adenocarcinoma. Clin Exp Med 4:93–98PubMedCrossRef

14.

Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB (2004) Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 50:1976–1983PubMedCrossRef

15.

Hunt RH (1996) The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes. Scand J Gastroenterol Suppl 220:3–9PubMedCrossRef

16.

IARC Working Group (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:1–241

17.

Jenab M, McKay JD, Ferrari P, Biessy C, Laing S, Capella Munar GM, Sala N, Pena S, Crusius JB, Overvad K, Jensen MK, Olsen A, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Georgila C, Psaltopoulou T, Mattiello A, Vineis P, Pala V, Palli D, Tumino R, Numans ME, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Sanchez MJ, Dorronsoro M, Navarro Sanchez C, Quiros JR, Hallmans G, Stenling R, Manjer J, Regner S, Key T, Bingham S, Khaw KT, Slimani N, Rinaldi S, Boffetta P, Carneiro F, Riboli E, Gonzalez C (2008) CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer 44:774–780PubMedCrossRef

18.

Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, Pietinen P, Dawsey SM, Albanes D, Virtamo J, Taylor PR (2006) Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17:117–125PubMedCrossRef

19.

Kamangar F, Cheng C, Abnet CC, Rabkin CS (2006) Interleukin-1B polymorphisms and gastric cancer risk—a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1920–1928PubMedCrossRef

20.

Kikuchi S, Nakajima T, Nishi T, Kobayashi O, Konishi T, Inaba Y, Wada O, Satou H, Ishibashi T, Ichikawa S, Okamoto N, Hirata T, Kubo T, Sato N, Miki K, Myoga A (1996) Association between family history and gastric carcinoma among young adults. Jpn J Cancer Res 87:332–336PubMed

21.

Koshida Y, Koizumi W, Sasabe M, Katoh Y, Okayasu I (2000) Association of Helicobacter pylori-dependent gastritis with gastric carcinomas in young Japanese patients: histopathological comparison of diffuse and intestinal type cancer cases. Histopathology 37:124–130PubMedCrossRef

22.

Kuipers EJ, Lee A, Klinkenberg-Knol EC, Meuwissen SG (1995) Review article: the development of atrophic gastritis—Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther 9:331–340PubMed

23.

Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG (1996) Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334:1018–1022PubMedCrossRef

24.

Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMed

25.

Lunet N, Barros H (2003) Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 106:953–960PubMedCrossRef

26.

Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M (2001) Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121:823–829PubMedCrossRef

27.

Mahmoud FA, Rivera NI (2002) The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 4:250–255PubMedCrossRef

28.

Masuda G, Tokunaga A, Shirakawa T, Togashi A, Kiyama T, Kato S, Matsukura N, Bou H, Watanabe M, Tajiri T (2007) Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years. Gastric Cancer 10:98–103PubMedCrossRef

29.

Milne AN, Carvalho R, Jansen M, Kranenbarg EK, van de Velde CJ, Morsink FM, Musler AR, Weterman MA, Offerhaus GJ (2008) Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival. J Clin Pathol 61:311–316PubMedCrossRef

30.

Milne AN, Carvalho R, Morsink FM, Musler AR, de Leng WW, Ristimaki A, fferhaus GJ (2006) Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 9:564–572CrossRef

31.

Milne AN, Sitarz R, Carvalho R, Carneiro F, Offerh, aus GJ (2007) Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr Mol Med 7:15–28PubMedCrossRef

32.

Milne AN, Sitarz R, Carvalho R, Polak MM, Ligtenberg M, Pauwels P, Offerhaus GJ, Weterman MA (2007) Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. Hum Pathol 38:903–913PubMedCrossRef

33.

Nicholls JC (1979) Stump cancer following gastric surgery. World J Surg 3:731–736PubMedCrossRef

34.

Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN (1994) Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29:425–429PubMedCrossRef

35.

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMed

36.

Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMed

37.

Rugge M, Busatto G, Cassaro M, Shiao YH, Russo V, Leandro G, Avellini C, Fabiano A, Sidoni A, Covacci A (1999) Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 85:2506–2511PubMedCrossRef

38.

Saijo Y, Tanaka M, Miki M, Usui K, Suzuki T, Maemondo M, Hong X, Tazawa R, Kikuchi T, Matsushima K, Nukiwa T (2002) Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor–stromal interaction. J Immunol 169:469–475PubMed

39.

Sinning C, Schaefer N, Standop J, Hirner A, Wolff M (2007) Gastric stump carcinoma—epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol 33:133–139PubMedCrossRef

40.

Song X, Voronov E, Dvorkin T, Fima E, Cagnano E, Benharroch D, Shendler Y, Bjorkdahl O, Segal S, Dinarello CA, Apte RN (2003) Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J Immunol 171:6448–6456PubMed

41.

Tersmette AC, Offerhaus GJ, Giardiello FM, Brand R, Tersmette KW, Tytgat GN, Vandenbroucke JP (1991) Long-term prognosis after partial gastrectomy for benign conditions. Survival and smoking-related death of 2633 Amsterdam postgastrectomy patients followed up since surgery between 1931 and 1960. Gastroenterology 101:148–153PubMed

42.

Thorban S, Bottcher K, Etter M, Roder JD, Busch R, Siewert JR (2000) Prognostic factors in gastric stump carcinoma. Ann Surg 231:188–194PubMedCrossRef

43.

Wallace JL, Cucala M, Mugridge K, Parente L (1991) Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 261:G559–G564PubMed

44.

Westerveld H, Visser L, Tanck M, van der Veen F, Repping S (2008) CAG repeat length variation in the androgen receptor gene is not associated with spermatogenic failure. Fertil Steril 89:253–259PubMedCrossRef

45.

Yano S, Nokihara H, Yamamoto A, Goto H, Ogawa H, Kanematsu T, Miki T, Uehara H, Saijo Y, Nukiwa T, Sone S (2003) Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci 94:244–252PubMedCrossRef

46.

Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, Sung JJ (2003) Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52:1684–1689PubMedCrossRef

Title: IL-1B −31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers
Authors: R. Sitarz
W. W. J. de Leng
M. Polak
F. H. M. Morsink
O. Bakker
W. P. Polkowski
R. Maciejewski
G. J. A. Offerhaus
A. N. Milne
Publication date: 01-09-2008
Publisher: Springer-Verlag
Published in: Virchows Archiv / Issue 3/2008
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-008-0642-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

IL-1B −31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2008

Parathyroid tissue in an adult’s cervical bronchogenic cyst

Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson–Fabry disease

Oncocytic adrenal cortical tumor with cytoplasmic inclusions and hyaline globules

AMACR expression in colorectal cancer is associated with left-sided tumor localization

Cadherin–catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck

Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium